trial · primary record
Immunomodulatory DC vaccines to target prostate cancer
Prostate Cancer Indications
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 30 |
| Primary completion | 2026-07-31 |
| Primary endpoint | Events of adverse effects after the DC vaccine injection |
| Registry ID | NCT07068555 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:39.048Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07068555
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.